Viewing Study NCT03202368


Ignite Creation Date: 2025-12-24 @ 5:37 PM
Ignite Modification Date: 2026-01-04 @ 4:07 PM
Study NCT ID: NCT03202368
Status: COMPLETED
Last Update Posted: 2020-09-04
First Post: 2017-06-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: An Extension Study to Evaluate Long-Term Safety of Subcutaneous (SC) Tocilizumab in Participants With Giant Cell Arteritis (GCA)
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module